1.SpyGlass in Diagnosis of Hepatocellular Carcinoma with Right Hepatic Duct Tumor Thrombus Hemorrhage: A Case Report.
Li-Hua GUO ; Min MIAO ; Guo-Liang YE
Chinese Medical Sciences Journal 2023;38(4):309-314
Hepatocelluar carcinoma presenting as a biliary duct tumor thrombus is a relatively rare entity, with poor prognosis. The primary clinical manifestation of this disease is obstructive jaundice, which can often be misdiagnosed. A 59-year-old female patient was admitted with sudden onset of abdominal pain. Laboratory tests suggested obstructive jaundice, and enhanced magnetic resonance imaging of the upper abdomen did not show obvious biliary dilatation. Endoscopic ultrasound and endoscopic retrograde cholangiopancreatography suggested an occupying lesion in the upper bile duct. SpyGlass and biopsy finally confirmed hepatocellular carcinoma with right hepatic duct tumor thrombus hemorrhage. The SpyGlass Direct Visualization System, as an advanced biliary cholangioscopy device, showed the advantages of single-person operation as well as easy access to and visualization of the lesion.
Female
;
Humans
;
Middle Aged
;
Carcinoma, Hepatocellular/diagnostic imaging*
;
Jaundice, Obstructive/etiology*
;
Liver Neoplasms/diagnostic imaging*
;
Hepatic Duct, Common/pathology*
;
Thrombosis/complications*
;
Hemorrhage/complications*
2.Gadolinium Ethoxybenzyl Diethylene-triamine-pentaacetic-acid-enhanced Magnetic Resonance Imaging Perfusion and Multiple Hepatobiliary-phase Imaging for Quantitative Assessment of Liver Fibrosis in Rat Models.
Jia XU ; Xuan WANG ; Yan YOU ; Hua Dan XUE ; Qin WANG ; Shi Tian WANG ; Zheng Yu JIN
Acta Academiae Medicinae Sinicae 2018;40(6):809-816
Objective To investigate the value of gadolinium ethoxybenzyl diethylene-triamine-pentaacetic-acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI) in detecting different stages of liver fibrosis in rats.Methods Rat models of liver fibrosis were induced by carbon tetrachloride intraperitoneal injection for 4 - 12 weeks (n=45). The control group was applied with 0.9% saline (n=15). The MRI protocol contained both dynamic contrast-enhanced sequence (60 continuous scans within 3 minutes,including three pre-contrast measurements) and multiple hepatobiliary-phase acquisitions (every 5 minutes after contrast injection,60 minutes in total). METAVIR score was used to grade liver fibrosis:normal (F0),mild fibrosis (F1 - F2),and advanced fibrosis (F3 - F4). Liver perfusion parameters [transfer constant (K ),extravascular extracellular volume fraction (V),initial area under curve (iAUC),maximum relative enhancement (RE),and time of maximum RE (T)] as well as hepatobiliary-phase parameters [RE at different time point,the decrease of RE (RE=RE - RE),and elimination half-life of RE (T)] were measured and compared with ANOVA analysis and Spearman rank correlation.Results Thirty-one rats completed MRI exams and were then divided into normal (n=10),mild fibrosis (n=10),and advanced fibrosis (n=11) groups. K ,V and iAUC decreased as liver fibrosis progressed (r=-0.631,P=0.002;r=-0.503,P=0.017;r=-0.446,P=0.037). K and V showed significant differences among three groups(F=7.011,P=0.005;F=4.656,P=0.023). K and V were significantly lower in advanced fibrosis group than in normal group (P=0.001,P=0.009). There were statistical significant differences of T,T and RE among groups(F=6.633,P=0.005;F=5.493,P=0.010;F=5.343,P=0.014). Compared to normal and mild fibrosis groups,advanced fibrosis group had significantly longer T and T (P=0.005,P=0.004;P=0.008,P=0.008)and significantly lower RE(P=0.007,P=0.012).Conclusion Perfusion and multi-hepatobiliary-phase parameters such as K ,V,T, T and RE obtained from Gd-EOB-DTPA-enhanced MRI,may be valuable for detecting and staging liver fibrosis.
Animals
;
Contrast Media
;
chemistry
;
Gadolinium DTPA
;
chemistry
;
Liver
;
diagnostic imaging
;
pathology
;
Liver Cirrhosis
;
diagnostic imaging
;
Magnetic Resonance Imaging
;
Rats
3.Correlation Between Dual-energy and Perfusion CT in Patients with Focal Liver Lesions Using Third-generation Dual-source CT Scanner.
Jia XU ; Yongchang ZHENG ; Xuan WANG ; Huadan XUE ; Shitian WANG ; Jixiang LIANG ; Zhengyu JIN
Acta Academiae Medicinae Sinicae 2017;39(1):74-79
Objective To compare measurements of dual-energy CT iodine map parameters and liver perfusion CT parameters in patients with focal liver lesions using a third-generation dual-source CT scanner. Methods Between November 2015 and August 2016,33 patients with non-cystic focal lesions of liver were enrolled in this study. CT examinations were performed with a third-generation dual-source CT. The study CT protocol included a perfusion CT and dual-energy arterial and portal venous scans,with a time interval of 15 minutes. Iodine attenuation was measured at five region of interests including areas of high,medium,and low density within the lesion,as well as right and left liver parenchyma from the iodine map,while arterial liver perfusion (ALP),portal venous liver perfusion (PVP),and hepatic perfusion index (HPI) at the same location were measured from perfusion CT. The Pearson product-moment correlation coefficient was used to evaluate the relationship between iodine attenuation and perfusion parameters. Results The iodine attenuation at arterial phase showed significant intra-individual correlation with ALP (r=0.812,95% CI=0.728-0.885,P<0.001)and PVP (r=-0.209,95% CI=-0.323--0.073,P=0.007),but not significantly correlated with HPI (r=0.058,95% CI=0.046-0.498,P=0.461). The iodine attenuation at portal venous phase showed significant correlation with PVP (r=0.214,95% CI=0.072-0.361,P=0.005) but not with HPI(r=0.036,95% CI=-0.002-0.242,P=0.649). The mean effective dose of arterial phase and portal venous phase of dual-energy CT together [(3.53±1.17)mSv] was significantly lower than that of the perfusion CT [(14.53±0.45)mSv](t=25.212,P<0.001). Conclusion Iodine attenuation from arterial phase of dual energy CT demonstrates significant correlation with ALP and PVP,and iodine attenuation from portal venous phase demonstrates significant correlation with PVP.
Contrast Media
;
Humans
;
Iodine
;
Liver
;
diagnostic imaging
;
pathology
;
Perfusion
;
Portal Vein
;
Tomography, X-Ray Computed
;
methods
4.Comparison of hepatic MDCT, MRI, and DSA to explant pathology for the detection and treatment planning of hepatocellular carcinoma.
Lauren M LADD ; Temel TIRKES ; Mark TANN ; David M AGARWAL ; Matthew S JOHNSON ; Bilal TAHIR ; Kumaresan SANDRASEGARAN
Clinical and Molecular Hepatology 2016;22(4):450-457
BACKGROUND/AIMS: The diagnosis and treatment plan for hepatocellular carcinoma (HCC) can be made from radiologic imaging. However, lesion detection may vary depending on the imaging modality. This study aims to evaluate the sensitivities of hepatic multidetector computed tomography (MDCT), magnetic resonance imaging (MRI), and digital subtraction angiography (DSA) in the detection of HCC and the consequent management impact on potential liver transplant patients. METHODS: One hundred and sixteen HCC lesions were analyzed in 41 patients who received an orthotopic liver transplant (OLT). All of the patients underwent pretransplantation hepatic DSA, MDCT, and/or MRI. The imaging results were independently reviewed retrospectively in a blinded fashion by two interventional and two abdominal radiologists. The liver explant pathology was used as the gold standard for assessing each imaging modality. RESULTS: The sensitivity for overall HCC detection was higher for cross-sectional imaging using MRI (51.5%, 95% confidence interval [CI]=36.2-58.4%) and MDCT (49.8%, 95% CI=43.7-55.9%) than for DSA (41.7%, 95% CI=36.2-47.3%) (P=0.05). The difference in false-positive rate was not statistically significant between MRI (22%), MDCT (29%), and DSA (29%) (P=0.67). The sensitivity was significantly higher for detecting right lobe lesions than left lobe lesions for all modalities (MRI: 56.1% vs. 43.1%, MDCT: 55.0% vs. 42.0%, and DSA: 46.9% vs. 33.9%; all P<0.01). The sensitivities of the three imaging modalities were also higher for lesions ≥2 cm vs. <2 cm (MRI: 73.4% vs. 32.7%, MDCT: 66.9% vs. 33.8%, and DSA: 62.2% vs. 24.1%; all P<0.01). The interobserver correlation was rated as very good to excellent. CONCLUSIONS: The sensitivity for detecting HCC is higher for MRI and MDCT than for DSA, and so cross-sectional imaging modalities should be used to evaluate OLT candidacy.
Adult
;
Aged
;
Angiography, Digital Subtraction
;
Carcinoma, Hepatocellular/*diagnostic imaging/pathology/therapy
;
Female
;
Humans
;
Liver Neoplasms/*diagnostic imaging/pathology/therapy
;
Liver Transplantation
;
Magnetic Resonance Imaging
;
Male
;
Middle Aged
;
Retrospective Studies
;
Sensitivity and Specificity
;
Tomography, X-Ray Computed
5.What we need to know when performing and interpreting US elastography.
So Hyun PARK ; So Yeon KIM ; Chong Hyun SUH ; Seung Soo LEE ; Kyoung Won KIM ; So Jung LEE ; Moon Gyu LEE
Clinical and Molecular Hepatology 2016;22(3):406-414
According to the increasing need for accurate staging of hepatic fibrosis, the ultrasound (US) elastography techniques have evolved significantly over the past two decades. Currently, US elastography is increasingly used in clinical practice. Previously published studies have demonstrated the excellent diagnostic performance of US elastography for the detection and staging of liver fibrosis. Although US elastography may seem easy to perform and interpret, there are many technical and clinical factors which can affect the results of US elastography. Therefore, clinicians who are involved with US elastography should be aware of these factors. The purpose of this article is to present a brief overview of US techniques with the relevant technology, the clinical indications, diagnostic performance, and technical and biological factors which should be considered in order to avoid misinterpretation of US elastography results.
Disease Progression
;
Elasticity Imaging Techniques/instrumentation/*methods
;
Fatty Liver/complications/diagnostic imaging
;
Humans
;
Hypertension, Portal/complications
;
Liver/*diagnostic imaging/physiopathology
;
Liver Cirrhosis/diagnostic imaging/pathology
6.Primary adenosquamous carcinoma of the liver: a case report.
Clinical and Molecular Hepatology 2016;22(4):503-508
Adenosquamous carcinoma of the liver is a rare variant of cholangiocarcinoma. It is known to be a highly aggressive tumor with a poor prognosis, but its pathogenesis remains unclear owing to limited data in the literature. We report a case of 56-year-old woman who presented with a 1-week history of epigastric pain. Magnetic resonance imaging revealed a 6.5-cm ill-defined mass with low signal intensity in the left lobe of the liver, which was suspicious of cholangiocarcinoma. The patient underwent left hemihepatectomy. Microscopically, the tumor consisted of malignant glandular and squamous components and staged as pT2aN1. Despite postoperative chemoradiation, the patient had recurrence 8 months after surgery.
Abdomen/diagnostic imaging
;
Carcinoma, Adenosquamous/diagnostic imaging/*pathology
;
Cholangiopancreatography, Endoscopic Retrograde
;
Female
;
Gallstones/surgery
;
Humans
;
Liver Neoplasms/diagnostic imaging/*pathology
;
Middle Aged
;
Sphincterotomy, Endoscopic
;
Tomography, X-Ray Computed
7.Undifferentiated embryonal sarcoma of the liver in an adult patient.
Kyu Ho LEE ; Mussin Nadiar MARATOVICH ; Kyoung Bun LEE
Clinical and Molecular Hepatology 2016;22(2):292-295
Undifferentiated embryonal sarcoma of the liver (UESL) is rare primary hepatic sarcoma and is known to occur in pediatric patients. This case is the UESL occurred in a 51-year old male patient. Multilocular cystic lesion was composed of primitive spindle cells without specific differentiation. This rare case would help to review differential diagnosis of primary sarcoma in liver and cystic neoplasm of the liver.
Abdomen/diagnostic imaging
;
Biomarkers, Tumor/blood
;
Desmin/metabolism
;
Diagnosis, Differential
;
Humans
;
Immunohistochemistry
;
Liver Neoplasms/blood/*pathology/surgery
;
Magnetic Resonance Imaging
;
Male
;
Middle Aged
;
Vimentin/metabolism
8.A case of portal hypertension by presumed as plexiform neurofibroma at the hepatic hilum.
Kyung Han LEE ; Sun Hong YOO ; Gi Tark NOH ; Won Suk HEO ; Byung Seong KO ; Jung Ah CHIO ; Hyo Jin CHO ; Jin Young CHOI ; Hee Jun KIM ; Won SOHN ; Sang Jong PARK ; Young Min PARK
Clinical and Molecular Hepatology 2016;22(2):276-280
Neurofibromas can occur anywhere in the body, but they usually involve the head, neck, pelvis, and extremities. Abdominal visceral involvement is rare, and intrahepatic involvement is even less common. We describe a patient who suffered from plexiform neurofibromatosis with liver involvement. A 49-year-old man, who had previously been diagnosed with neurofibromatosis, underwent esophagogastroduodenoscopy and abdominal ultrasonography for screening purposes. Esophagogastroduodenoscopy showed grade 2 esophageal varices and abdominal ultrasonography showed conglomerated nodules with echogenic appearances in the perihepatic space. Magnetic resonance imaging showed presumed plexiform neurofibroma involving the lesser sac and hepatic hilum and encasing the common hepatic artery celiac trunk and superior mesenteric artery left portal triad. We report an unusual case of portal hypertension attributed to the compressive narrowing of the portal vein by presumed as plexiform neurofibroma at the lesser sac and hepatic hilum.
Abdomen/diagnostic imaging
;
Endoscopy, Digestive System
;
Esophageal and Gastric Varices/pathology
;
Hepatic Artery/diagnostic imaging
;
Humans
;
Hypertension, Portal/*diagnosis
;
Liver/diagnostic imaging
;
Magnetic Resonance Imaging
;
Male
;
Middle Aged
;
Neurofibroma, Plexiform/*diagnosis/diagnostic imaging
;
Tomography, X-Ray Computed
;
Ultrasonography
9.Drug-induced liver injury caused by iodine-131.
Chei Won KIM ; Ji Sun PARK ; Se Hwan OH ; Jae Hyung PARK ; Hyun Ik SHIM ; Jae Woong YOON ; Jin Seok PARK ; Seong Bin HONG ; Jun Mi KIM ; Trong Binh LE ; Jin Woo LEE
Clinical and Molecular Hepatology 2016;22(2):272-275
Iodine-131 is a radioisotope that is routinely used for the treatment of differentiated thyroid cancer after total or near-total thyroidectomy. However, there is some evidence that iodine-131 can induce liver injury . Here we report a rare case of drug-induced liver injury (DILI) caused by iodine-131 in a patient with regional lymph node metastasis after total thyroidectomy. A 47-year-old woman was admitted with elevated liver enzymes and symptoms of general weakness and nausea. Ten weeks earlier she had undergone a total thyroidectomy for papillary thyroid carcinoma and had subsequently been prescribed levothyroxine to reduce the level of thyroid-stimulating hormone. Eight weeks after surgery she underwent iodine-131 ablative therapy at a dose of 100 millicuries, and subsequently presented with acute hepatitis after 10 days. To rule out all possible causative factors, abdominal ultrasonography, endoscopic ultrasonography (on the biliary tree and gall bladder), and a liver biopsy were performed. DILI caused by iodine-131 was suspected. Oral prednisolone was started at 30 mg/day, to which the patient responded well.
Abdomen/diagnostic imaging
;
Chemical and Drug Induced Liver Injury/*diagnosis/drug therapy
;
Female
;
Humans
;
Iodine Radioisotopes/chemistry
;
Lymph Nodes/pathology
;
Lymphatic Metastasis
;
Middle Aged
;
Prednisolone/therapeutic use
;
Thyroid Neoplasms/drug therapy/surgery
;
Thyroidectomy
;
Thyroxine/therapeutic use
;
Ultrasonography
10.Primary squamous cell carcinoma of the liver: a case report.
Tae Kyung YOO ; Byung Ik KIM ; Eun Na HAN ; Dong Hyung KIM ; Jung Hee YOO ; Seung Jae LEE ; Yong Kyun CHO ; Hong Joo KIM
Clinical and Molecular Hepatology 2016;22(1):177-182
Primary squamous cell carcinoma (SCC) of the liver is very rare, and few cases have been reported in Korea. Primary SCC of the liver is known to be associated with hepatic cysts and intrahepatic stones. A 71-year-old male was admitted to our hospital, and a abdominal computed tomography scan revealed a 10 × 6 cm mass in the liver. Analysis of a biopsy sample suggested SCC, and so our team performed a thorough workup to find the primary lesion, which was revealed hepatoma as a pure primary SCC of the liver with multiple distant metastases. The patient was treated with one cycle of radiotherapy, transferred to another hospital for hospice care, and then died 1 month after discharge.
Abdomen/diagnostic imaging
;
Aged
;
Carcinoma, Squamous Cell/*diagnosis/pathology/radiotherapy
;
Humans
;
Immunohistochemistry
;
Keratins/metabolism
;
Liver Neoplasms/*diagnosis/pathology/radiotherapy
;
Male
;
Palliative Care
;
Positron-Emission Tomography
;
Tomography, X-Ray Computed

Result Analysis
Print
Save
E-mail